This announcement is a separate document:
中外製薬：暫定連結財務諸表（IFRS）（未監査）（2024会計年度の第2四半期）
Chugai Pharmaceutical: Provisional linked financial statements (IFRS) (unaudited) (Q2 of fiscal year 2024)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated